CZ301598A3 - Přípravky obsahující SCF a způsoby jejich použití - Google Patents

Přípravky obsahující SCF a způsoby jejich použití Download PDF

Info

Publication number
CZ301598A3
CZ301598A3 CZ983015A CZ301598A CZ301598A3 CZ 301598 A3 CZ301598 A3 CZ 301598A3 CZ 983015 A CZ983015 A CZ 983015A CZ 301598 A CZ301598 A CZ 301598A CZ 301598 A3 CZ301598 A3 CZ 301598A3
Authority
CZ
Czechia
Prior art keywords
scf
recombinant human
cells
ser
analog
Prior art date
Application number
CZ983015A
Other languages
Czech (cs)
English (en)
Inventor
Hsieng Sen Lu
Original Assignee
Amgen Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc. filed Critical Amgen Inc.
Publication of CZ301598A3 publication Critical patent/CZ301598A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CZ983015A 1996-04-05 1997-04-03 Přípravky obsahující SCF a způsoby jejich použití CZ301598A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/628,428 US5885962A (en) 1996-04-05 1996-04-05 Stem cell factor analog compositions and method

Publications (1)

Publication Number Publication Date
CZ301598A3 true CZ301598A3 (cs) 1999-01-13

Family

ID=24518837

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ983015A CZ301598A3 (cs) 1996-04-05 1997-04-03 Přípravky obsahující SCF a způsoby jejich použití

Country Status (17)

Country Link
US (1) US5885962A (de)
EP (1) EP0904367B1 (de)
JP (1) JP4066388B2 (de)
KR (1) KR20000004951A (de)
CN (1) CN1214734A (de)
AT (1) ATE363488T1 (de)
AU (1) AU726663B2 (de)
BR (1) BR9708578A (de)
CA (1) CA2249181C (de)
CZ (1) CZ301598A3 (de)
DE (1) DE69737766T2 (de)
ES (1) ES2286830T3 (de)
IL (1) IL126221A0 (de)
NO (1) NO984491L (de)
SK (1) SK131098A3 (de)
WO (1) WO1997038101A1 (de)
YU (1) YU41798A (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0789761B1 (de) * 1994-11-04 2005-07-20 Applied Research Systems ARS Holding N.V. Menschliche scf, eine spleissvariante davon,ihre pharmazeutische verwendung
US5969105A (en) * 1996-10-25 1999-10-19 Feng; Yiqing Stem cell factor receptor agonists
US6967092B1 (en) 1996-10-25 2005-11-22 Mc Kearn John P Multi-functional chimeric hematopoietic receptor agonists
US6291661B1 (en) 1998-07-02 2001-09-18 Immunex Corporation flt3-L mutants and method of use
BR0012429A (pt) * 1999-07-15 2002-09-17 Genetics Inst Fórmulações para il-11
DE60044945D1 (de) * 1999-12-23 2010-10-21 Univ Geneve Auf scf peptid basiertes basolaterales sortiersignal und inhibitoren dafür
AU2002362088A1 (en) * 2001-12-06 2003-06-23 Catholic University Method and composition for inducing weight loss
WO2003103608A2 (en) * 2002-06-11 2003-12-18 The Burnham Institute Neuroprotective synergy of erythropoietin and insulin-like growth factor
AU2012205718B2 (en) * 2011-01-10 2017-07-06 The Regents Of The University Of Michigan Stem cell factor inhibitor
US20150196622A1 (en) * 2012-08-21 2015-07-16 Ali Nayer Materials and methods for modulating glucose uptake
WO2015006554A1 (en) 2013-07-10 2015-01-15 The Regents Of The University Of Michigan Therapeutic antibodies and uses thereof
CN105985424B (zh) * 2015-01-30 2019-08-23 苏州方舟生物医药有限公司 一种干细胞因子功能性肽段及其应用
WO2016187820A1 (zh) * 2015-05-26 2016-12-01 中国科学院广州生物医药与健康研究院 一种人原代细胞培养基及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
RU2212411C2 (ru) * 1989-10-16 2003-09-20 Эмджен Инк. Полипептид, обладающий гемопоэтической биологической активностью фактора стволовых клеток (варианты), днк (варианты), экспрессирующий вектор (варианты), фармацевтическая композиция для гемопоэтической терапии, способ получения полипептида и способ его использования (варианты)
SG59931A1 (en) * 1989-10-16 1999-02-22 Amgen Inc Stem cell factor
AU8196891A (en) * 1990-06-25 1992-01-23 Immunex Corporation Mast cell growth factor
US20030125519A1 (en) * 1990-08-27 2003-07-03 Peter Besmer Ligand for the c-kit receptor and methods of use thereof
DE4224050A1 (de) * 1991-07-31 1993-02-04 Hoffmann La Roche Loesliche kit-liganden
US5525708A (en) * 1994-03-28 1996-06-11 Cytomed, Inc. Covalent dimer of kit ligand

Also Published As

Publication number Publication date
JP4066388B2 (ja) 2008-03-26
IL126221A0 (en) 1999-05-09
EP0904367A1 (de) 1999-03-31
YU41798A (sh) 1999-07-28
DE69737766T2 (de) 2007-10-11
KR20000004951A (ko) 2000-01-25
NO984491L (no) 1998-10-05
US5885962A (en) 1999-03-23
CA2249181C (en) 2009-11-17
DE69737766D1 (de) 2007-07-12
CN1214734A (zh) 1999-04-21
EP0904367B1 (de) 2007-05-30
CA2249181A1 (en) 1997-10-16
AU2606497A (en) 1997-10-29
AU726663B2 (en) 2000-11-16
SK131098A3 (en) 1999-03-12
ATE363488T1 (de) 2007-06-15
ES2286830T3 (es) 2007-12-01
BR9708578A (pt) 1999-08-03
WO1997038101A1 (en) 1997-10-16
JP2000508170A (ja) 2000-07-04
NO984491D0 (no) 1998-09-25

Similar Documents

Publication Publication Date Title
KR100505172B1 (ko) 키메라 인터루킨-6 용해성 수용체/리간드 단백질, 이의유사체 및 용도
AU734594B2 (en) Circularly permuted polypeptides as novel stem cell factor receptor agonists
AU646514B2 (en) Chimeric fibroblast growth factor
KR100393508B1 (ko) 인간 인터루킨 4의 안타고니스트 또는 부분적 아고니스트로서의 신규hIL-4 변이단백질
JP2541761B2 (ja) ミュレル管抑制物質様ポリペプチドおよびその製造方法
KR100334739B1 (ko) 절단된신경교세포주-유래신경영양성인자단백질산물
CZ301598A3 (cs) Přípravky obsahující SCF a způsoby jejich použití
JPH11507367A (ja) エリトロポエチン受容体に結合する化合物およびペプチド
CA2142860A1 (en) Human interleukin-13
CA2268001A1 (en) Circularly permuted erythropoietin receptor agonists
JPH06505631A (ja) 巨核球刺激因子
CN110256575A (zh) 一种长效重组人生长激素融合蛋白及其工程细胞
AU733964B2 (en) Novel flt-3 receptor agonists
EP0760858A1 (de) Hybrides molekül mit der formrl gm--csf-l-epo oder epo-l-gm-csf für hämatopoetische stimulierung
JPH08301899A (ja) Ｉｇｆ−１スーパーアゴニスト
CA2134030A1 (en) Soluble interferon .alpha.-receptor, its preparation and use
AU2199895A (en) Covalent dimers of kit ligand and flt-3/flk-2 ligand
JPH11510062A (ja) 多機能性造血受容体アゴニスト
AU6972198A (en) Flt3 ligand chimeric proteins
AU703627B2 (en) Interleuken-3 (IL-3) receptor agonists
JP2001511641A (ja) インターロイキン―５のアンタゴニスト
WO1999051622A1 (en) Avian il-15 nucleotides and polypeptides, and methods of immunizing poultry using avian il-15
CZ346799A3 (cs) Chimérické proteiny jako flt3 ligandy
MXPA00002467A (en) Mpl ligand analogs

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic